RMG Acquisition Corp. III (RMGCF) 10-Q 22 Nov 21 2021 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2021	Nov. 22, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity File Number	001-40013
Entity Registrant Name	RMG ACQUISITION CORP. III
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1574120
Entity Address, Address Line One	57 Ocean, Suite 403
Entity Address, Address Line Two	5775 Collins Avenue
Entity Address, City or Town	Miami Beach
Entity Address State Or Province	FL
Entity Address, Postal Zip Code	33140
City Area Code	786
Local Phone Number	584-8352
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001838108
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant
Trading Symbol	RMGCU
Security Exchange Name	NASDAQ
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary shares included as part of the units
Trading Symbol	RMGC
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		48,300,000
Redeemable Warrants Exercisable For Class Common Stock
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units
Trading Symbol	RMGCW
Security Exchange Name	NASDAQ
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		12,075,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 191,011
Prepaid expenses	756,667	$ 10,221
Total current assets	947,678	10,221
Deferred offering costs		25,000
Investments held in Trust Account	483,040,207
Total Assets	483,987,885	35,221
Current liabilities:
Accounts payable	21,558
Accrued expenses	90,287	25,000
Total current liabilities	111,845	25,000
Deferred legal fees	250,000
Deferred underwriting commissions	16,905,000
Derivative warrant liabilities	16,267,500
Total Liabilities	33,534,345	25,000
Class A ordinary shares; 48,300,000 and no shares subject to possible redemption at $10.00 per share at September 30 ,2021 and December 31, 2020, respectively	483,000,000
Shareholders' Equity:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30 ,2021 and December 31, 2020, respectively	0	0
Additional paid-in capital		23,792
Accumulated deficit	(32,547,668)	(14,779)
Total shareholders' (deficit) equity	(32,546,460)	10,221
Total Liabilities and Shareholders' (Deficit) Equity	483,987,885	35,221
Class A Common Stock
Shareholders' Equity:
Common stock	0	0
Total shareholders' (deficit) equity	0	0
Class B Common Stock
Shareholders' Equity:
Common stock	1,208	1,208
Total shareholders' (deficit) equity	$ 1,208	$ 1,208

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Temporary Equity, Shares Outstanding		0
Class A Common Stock
Common shares, shares issued		0
Common shares, shares outstanding		0
Temporary Equity, Shares Outstanding	48,300,000	0
Class A Common Stock Subject to Redemption
Temporary Equity, Shares Outstanding	48,300,000	0
Purchase price, per unit	$ 10	$ 10
Class A Common Stock Not Subject to Redemption
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	500,000,000	500,000,000
Common shares, shares issued	48,300,000
Common shares, shares outstanding	48,300,000
Class B Common Stock
Common shares, par value, (per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	50,000,000	50,000,000
Common shares, shares issued	12,075,000	12,075,000
Common shares, shares outstanding	12,075,000	12,075,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
General and administrative expenses	$ 283,830	$ 1,513,445
Loss from operations	(283,830)	(1,513,445)
Other income (expense)
Change in fair value of derivative warrant liabilities	6,077,950	7,537,410
Financing costs - warrant liabilities		(734,320)
Interest income	13	47
Unrealized gain on investments held in Trust Account	6,216	40,207
Total other income (expense)	6,084,179	6,843,344
Net income (loss)	$ 5,800,349	$ 5,329,899
Weighted average Class B ordinary shares outstanding, basic and diluted	12,075,000	11,850,000
Basic and diluted net income per ordinary share	$ 0.10	$ 0.10
Common Stock Subject to Redemption [Member]
Other income (expense)
Weighted average Class A ordinary shares outstanding, basic and diluted	48,300,000	41,098,909
Basic and diluted net income per ordinary share	$ 0.10	$ 0.10

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Class A Common Stock	Class B Common Stock
Balance at the beginning at Dec. 31, 2020	$ 10,221	$ 23,792	$ (14,779)	$ 0	$ 1,208
Balance at the beginning (in shares) at Dec. 31, 2020				0	12,075,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accrection on Class A ordinary shares subject to possible redemption	(39,269,845)	(1,407,057)	(37,862,788)
Excess purchase price above fair value of private	1,383,265	1,383,265
Net income (loss)	(2,198,937)		(2,198,937)
Balance at the end at Mar. 31, 2021	(40,075,296)		(40,076,504)	$ 0	$ 1,208
Balance at the end (in shares) at Mar. 31, 2021				0	12,075,000
Balance at the beginning at Dec. 31, 2020	10,221	23,792	(14,779)	$ 0	$ 1,208
Balance at the beginning (in shares) at Dec. 31, 2020				0	12,075,000
Balance at the end at Jun. 30, 2021	(38,346,809)		(38,348,017)	$ 0	$ 1,208
Balance at the end (in shares) at Jun. 30, 2021				0	12,075,000
Balance at the beginning at Dec. 31, 2020	10,221	$ 23,792	(14,779)	$ 0	$ 1,208
Balance at the beginning (in shares) at Dec. 31, 2020				0	12,075,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,329,899			$ 4,279,869	$ 1,050,030
Balance at the end at Sep. 30, 2021	(32,546,460)		(32,547,668)	$ 0	$ 1,208
Balance at the end (in shares) at Sep. 30, 2021				0	12,075,000
Balance at the beginning at Mar. 31, 2021	(40,075,296)		(40,076,504)	$ 0	$ 1,208
Balance at the beginning (in shares) at Mar. 31, 2021				0	12,075,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,728,487		1,728,487
Balance at the end at Jun. 30, 2021	(38,346,809)		(38,348,017)	$ 0	$ 1,208
Balance at the end (in shares) at Jun. 30, 2021				0	12,075,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,800,349		5,800,349	$ 4,640,279	$ 1,160,070
Balance at the end at Sep. 30, 2021	$ (32,546,460)		$ (32,547,668)	$ 0	$ 1,208
Balance at the end (in shares) at Sep. 30, 2021				0	12,075,000

UNAUDITED CONDENSED STATEMENT O

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss			$ 5,329,899
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative warrant liabilities			(7,537,410)
Financing costs - warrant liabilities			734,320
Unrealized gain on investments held in Trust Account			(40,207)
Changes in operating assets and liabilities:
Prepaid expenses			(746,446)
Accounts payable			21,558
Accrued expenses			20,287
Net cash used in operating activities	$ (1,365,329)	$ (1,952,139)	(2,217,999)
Cash Flows from Investing Activities:
Cash deposited in Trust Account			(483,000,000)
Net cash used in investing activities	(483,000,000)	(483,000,000)	(483,000,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party			30,212
Repayment of note payable to related party			(135,000)
Proceeds received from initial public offering, gross			483,000,000
Proceeds received from private placement			12,324,495
Offering costs paid			(9,810,697)
Net cash provided by financing activities	485,508,800	(485,409,010)	485,409,010
Net increase in cash			191,011
Cash - beginning of the period	0	0	0
Cash—end of the period			191,011
Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accrued expenses	85,450	(70,000)	70,000
Offering costs paid by related party under promissory note	104,788	(104,788)	104,788
Reversal of accrued expenses	25,000	(25,000)	25,000
Deferred legal fees	250,000	(250,000)	250,000
Deferred underwriting commissions	$ 16,905,000	$ (16,905,000)	$ 16,905,000

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1 Description of Organization and Business Operations RMG Acquisition Corp. III (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on December 23, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (“Business Combination”). As of September 30, 2021, the Company had not yet commenced operations. All activity for the period from December 23, 2020 (inception) through September 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is RMG Sponsor III, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on February 4, 2021. On February 9, 2021, the Company consummated its Initial Public Offering of 48,300,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 6,300,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of $483.0 million, and incurring offering costs of approximately $27.1 million, of which approximately $16.9 million was for deferred underwriting commissions and $250,000 was for deferred legal fees (Note 7 Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 8,216,330 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $12.3 million (Note 5 Upon the closing of the Initial Public Offering and the Private Placement, $483.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and have been invested in United States government treasury bills with a maturity of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations, expenses relating to the administration of the trust account and limited withdrawals for working capital). The per-share reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7 6 Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or February 9, 2023, (the “Combination Period”), the Company will (1) cease all operations except for the purpose of winding up; (2) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the Public Shares, at a per-share The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 7 will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, expenses relating to the administration of the trust account and limited withdrawals for working capital, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern As of September 30, 2021, the Company had approximately $191,000 in its operating bank account and Further, the Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued. The Company’s liquidity needs to date have been satisfied through a payment of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 6 6 6 In connection with the Company’s assessment of going concern considerations in accordance with the FASB ASC Topic 205-40,

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	9 Months Ended
	Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	Note 2. Restatement of Previously Issued Financial Statements In preparation of the Company’s unaudited condensed financial statements as of and for quarterly period ended September 30, 2021, the Company concluded it should restate its previously issued financial statements to classify all Class A ordinary shares subject to possible redemption in temporary equity. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, in ASC 480-10-S99, $5,000,001. Previously, the Company did not consider redeemable shares classified as temporary equity as part of net tangible assets. Effective with these condensed financial statements, the Company revised this interpretation to include temporary equity in net tangible assets. As a result, the Company restated its previously filed financial statements to present all Class A ordinary shares subject to possible redemption as temporary equity and to recognize accretion from the initial book value to redemption value at the time of its Initial Public Offering. The Company’s previously filed financial statements that contained the error were reported in the Company’s Form 8-K filed with the SEC on February 16, 2021 (the “Post-IPO Balance Sheet”) and the Company’s Form 10-Qs for the quarterly periods ended March 31, 2021, and June 30, 2021 (the “Affected Quarterly Periods”). Impact of the Restatement The change in the carrying value of the Class A ordinary shares subject to possible redemption in the Post-IPO Balance Sheet resulted in a decrease of approximately $5.7 million in additional paid-in capital and an increase of approximately $37.8 million to accumulated deficit, as well as a reclassification of $43.6 million Class A ordinary shares from permanent equity to temporary equity. As of February 9, 2021 As Previously Adjustment As Restated Total assets $ 486,762,576 $ 486,762,576 Total liabilities $ 42,383,637 $ 42,383,637 Class A ordinary shares subject to redemption 439,378,930 43,621,070 483,000,000 Preference shares — — — Class A ordinary shares 436 (436 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 5,780,890 (5,780,890 ) — Accumulated deficit (782,525 ) (37,839,744 ) (38,622,269 ) Total shareholders’ equity (deficit) $ 5,000,009 $ (43,621,070 ) $ (38,621,061 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 486,762,576 $ — $ 486,762,576 The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Quarterly Periods is presented below. The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021: As of March 31, 2021 As Previously Adjustment As Restated Total assets $ 485,217,955 $ 485,217,955 Total liabilities $ 42,293,251 $ 42,293,251 Class A ordinary shares subject to redemption 437,924,700 45,075,300 483,000,000 Preference shares — — — Class A ordinary shares 451 (451 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 7,212,061 (7,212,061 ) — Accumulated deficit (2,213,716 ) (37,862,788 ) (40,076,504 ) Total shareholders’ equity (deficit) $ 5,000,004 $ (45,075,300 ) $ (40,075,296 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 485,217,955 $ — $ 485,217,955 The table below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021: For the three months ended March 31, 2021 As Previously Adjustment As Restated Cash Flow used in Operating Activities $ (1,365,329 ) $ — $ (1,365,329 ) Cash Flow used in Investing Activities $ (483,000,000 ) $ — $ (483,000,000 ) Cash Flows provided by Financing Activities $ 485,508,800 $ — $ 485,508,800 Supplemental Disclosure of Noncash Financing Activities Offering costs included in accounts payable $ 84,340 $ — $ 84,340 Offering costs included in accrued expenses $ 85,450 $ — $ 85,450 Offering costs paid by related party under promissory note $ 104,788 $ — $ 104,788 Reversal of accrued expenses $ 25,000 $ — $ 25,000 Deferred legal fees $ 250,000 $ — $ 250,000 Deferred underwriting commissions $ 16,905,000 $ — $ 16,905,000 Initial value of Class A ordinary shares subject to possible redemption $ 439,378,930 $ (439,378,930 ) $ — Change in value of Class A ordinary shares subject to possible redemption $ (1,454,230 ) $ 1,454,230 $ — The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021: As of June 30, 2021 As Previously Adjustment As Restated Total assets $ 484,399,219 $ 484,399,219 Total liabilities $ 39,746,028 $ 39,746,028 Class A ordinary shares subject to redemption 439,653,190 43,346,810 483,000,000 Preference shares — — — Class A ordinary shares 433 (433 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 5,483,589 (5,483,589 ) — Accumulated deficit (485,229 ) (37,862,788 ) (38,348,017 ) Total shareholders’ equity $ 5,000,001 $ (43,346,810 ) $ (38,346,809 ) Total liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit $ 484,399,219 $ — $ 484,399,219 The table below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: For the six months ended June 30, 2021 As Previously Adjustment As Restated Cash Flow used in Operating Activities $ (1,952,139 ) $ — $ (1,952,139 ) Cash Flows used in Investing Activities $ (483,000,000 ) $ — $ (483,000,000 ) Cash Flows provided by Financing Activities $ 485,409,010 $ — $ (485,409,010 ) Supplemental Disclosure of Noncash Financing Activities Offering costs included in accrued expenses $ 70,000 $ — $ (70,000 ) Offering costs paid by related party under promissory note $ 104,788 $ — $ (104,788 ) Reversal of accrued expenses $ 25,000 $ — $ (25,000 ) Deferred legal fees $ 250,000 $ — $ (250,000 ) Deferred underwriting commissions $ 16,905,000 $ — $ (16,905,000 ) Initial value of Class A ordinary shares subject to possible redemption $ 439,378,930 $ (439,378,930 ) $ — Change in value of Class A ordinary shares subject to possible redemption $ 274,260 $ (274,260 ) $ — In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company has revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares participate pro rata in the income and losses of the Company. The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented below for the Affected Quarterly Periods: EPS for Class A ordinary shares (redeemable) As Previously Adjustment As Adjusted Form 10-Q (March 31, 2021) - three months ended March 31, 2021 Net loss $ (2,198,937 ) $ — $ (2,198,937 ) Weighted average shares outstanding 43,935,042 (17,160,042 ) 26,775,000 Basic and diluted earnings per share $ — ($0.06 ) ($0.06 ) Form 10-Q (June 30, 2021) - three months ended June 30, 2021 Net income $ 1,728,487 $— $ 1,728,487 Weighted average shares outstanding 43,794,369 (4,505,631 ) 48,300,000 Basic and diluted earnings per share $ — $ 0.03 $ 0.03 Form 10-Q (June 30, 2021) - six months ended June 30, 2021 Net loss $ (470,450 ) $ — $ (470,450 ) Weighted average shares outstanding 43,844,893 (6,366,204 ) 37,478,689 Basic and diluted earnings per share $ — ($0.01 ) ($0.01 ) EPS for Class B ordinary shares (non-redeemable) As Previously Adjustment As Adjusted Form 10-Q (March 31, 2021) - three months ended March 31, 2021 Net loss $ (2,198,937 ) $— $ (2,198,937 ) Weighted average shares outstanding 13,865,976 (2,492,878 ) 11,373,098 Basic and diluted earnings per share ($0.16 ) $ 0.10 ($0.06 ) Form 10-Q (June 30, 2021) - three months ended June 30, 2021 Net income $ 1,728,487 $ — $ 1,728,487 Weighted average shares outstanding 16,580,631 (4,505,631 ) 12,075,000 Basic and diluted earnings per share $ 0.10 ($0.07 ) $ 0.03 Form 10-Q (June 30, 2021) - six months ended June 30, 2021 Net loss $ (470,450 ) $— $ (470,450 ) Weighted average shares outstanding 15,230,803 (3,508,672 ) 11,722,131 Basic and diluted earnings per share ($0.03 ) $ 0.02 ($0.01 )

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3—Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Current Report on Form 8-K In April 2021, the Company identified a misstatement in its accounting treatment for warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (collectively, the “Warrants”) as presented in its audited balance sheet as of February 9, 2021 included in its Current Report on Form 8-K, Accounting Changes and Error Corrections Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides non-emerging Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2021 and December 31, 2020. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the balance sheet. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Derivative Warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Warrants issued in connection with our Initial Public Offering have subsequently been measured based on the listed market price of such warrants. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred in connection with the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2021, 48,300,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. There were no Class A ordinary shares issued or outstanding as of December 31, 2020.​​​​​​​ Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.​​​​​​​ Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC more-likely-than-not There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net income ( loss) per ordinary share The Company has two classes of shares issued and outstanding: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,876,330, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2021. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share, as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each ordinary share class: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 4,640,279 $ 1,160,070 $ 4,279,869 $ 1,050,030 Denominator: Basic and diluted weighted average common shares outstanding 48,300,000 12,075,000 48,300,000 11,850,000 Basic and diluted net income per common share $ 0.10 $ 0.10 $ 0.09 $ 0.09 Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 2020-06”), 2020-06 The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2021
Initial Public Offering
Initial Public Offering	Note 4 - On February 9, 2021, the Company consummated its Initial Public Offering of 48,300,000 Units, including 6,300,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $483.0 million, and incurring offering costs of approximately $27.1 million, of which approximately $16.9 million was for deferred underwriting commissions and $250,000 was for deferred legal fees. Each Unit consists of one Class A ordinary share and one 9

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 Founder Shares In December 2020, the Sponsor paid an aggregate of $25,000 to cover for certain expenses on behalf of the Company in exchange for issuance of 10,062,500 ordinary shares (the “Founder Shares”). On January 30, 2021, the Company effectuated a 5-for- 6 The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (1) one year after the completion of the initial Business Combination; and (2) subsequent to the initial Business Combination (x) if the last reported sale price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 8,216,330 Private Placement Warrants at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of approximately $12.3 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. Related Party Loans On December 30, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders’ discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement Commencing on the effective date of the Registration Statement, the Company agreed to pay an affiliate of the Sponsor a total of $20,000 per month for office space, administrative and support services (including salaries). Upon the Company’s liquidation, the Company will cease paying these monthly fees. Upon completion of the Initial Business Combination, the Company will pay to such affiliate an amount equal to $20,000 multiplied by the number of whole months remaining between the date of the completion of the Initial Business Combination and the date that is 24 months from the closing of the Offering. The Company incurred approximately $60,000 and $160,000 in expenses in connection with such services during the three and nine months ended September 30, 2021, respectively, as reflected in the accompanying statement of operations and had nil included in accrued expenses-related party in connection with such services. The Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6 Registration and Shareholder Rights Agreement The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45 -day The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $9.7 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $16.9 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	9 Months Ended
	Sep. 30, 2021
Temporary Equity Disclosure [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 7 The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of $0.0001 per share. As of September 30, 2021, there were 48,300,000 Class A ordinary shares issued and outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets. There were no Class A ordinary shares issued or outstanding as of December 31, 2020. The Class A ordinary shares issued in the Initial Public Offering were recognized in Class A ordinary shares subject to possible redemption as follows: Gross Proceeds $ 483,000,000 Proceeds from over-allotment 10,941,230 Less: Offering costs allocated to Class A shares subject to possible redemption (26,406,165 ) Proceeds allocated to Public Warrants at issuance (23,804,910 ) Plus: Accrection on Class A ordinary shares subject to possible redemption amount 39,269,845 Class A ordinary shares subject to possible redemption $ 483,000,000

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2021
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Note 8 Preference Shares - Class A Ordinary Shares - At September 30, 2021, there shares issued and outstanding, all of which are subject to possible redemption and have been classified as temporary equity (see Note 7). There were no Class A ordinary shares issued or outstanding as of December 31, 2020 Class B Ordinary Shares - 5-for- 6 Only holders of Class B ordinary shares will have the right to vote on the election of directors prior to the initial Business Combination. Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of the shareholders, except as required by law. Each ordinary share will have one vote on all such matters. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one sub-divisions, as-converted

Derivative Warrant Liabilities

Derivative Warrant Liabilities	9 Months Ended
	Sep. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Warrant Liabilities	Note 9 As of September 30, 2021, the Company had 9,660,000 and 8,216,330 Public Warrants and Private Placement Warrants, respectively, outstanding. As of December 31, 2020, the Company did not have any Public Warrants or Private Placement Warrants outstanding Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). The Company agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, requires holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described under “Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under the caption “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30 -trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided • if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30 - trading • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading The “fair market value” of Class A ordinary shares shall mean the average reported last sale price of Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10 The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Quoted Prices Significant Other Significant Other in Observable Unobservable Active Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 483,040,207 $ — $ — Liabilities: Derivative warrant liabilities—public $ 8,790,600 $ — $ — Derivative warrant liabilities—private $ — $ — $ 7,476,860 Transfers to/from Levels 1 2 Level 1 assets include investments in money market funds and U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. For the three and nine months ended September 30, 2021, the Company recognized a change to the statement of operations resulting from a decrease in the fair value of liabilities of approximately $6.1 million and $7.5 million, respectively, presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility for its Private Placement Warrants based on the implied volatility from the Company’s traded warrants and from historical volatility of select peer companies ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: February 9, 2021 As of September 30, 2021 Share price $ 9.73 $ 9.73 Volatility 24.2 % 18.2 % Expected life of the options to convert 6.18 5.71 Risk-free rate 0.65 % 1.10 % Dividend yield — — The change in the level 3 fair value of the derivative warrant liabilities for the nine months ended September 30, 2021 is summarized as follows: Derivative warrant liabilities at January 13, 2021 (inception) $ — Issuance of Public and Private Warrants 23,804,910 Change in fair value of derivative warrant liabilities 1,221,950 Transfer of Public Warrants to Level 1 (13,524,000 ) Derivative warrant liabilities at March 31, 2021 11,502,860 Change in fair value of derivative warrant liabilities (1,232,450 ) Derivative warrant liabilities at June 30, 2021 10,270,410 Change in fair value of derivative warrant liabilities (2,793,550 ) Derivative warrant liabilities at September 30, 2021 $ 7,476,860

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11—Subsequent Events The Company evaluated subsequent events and transactions that

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and nine months ended September 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Current Report on Form 8-K In April 2021, the Company identified a misstatement in its accounting treatment for warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants (collectively, the “Warrants”) as presented in its audited balance sheet as of February 9, 2021 included in its Current Report on Form 8-K, Accounting Changes and Error Corrections
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides non-emerging
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of September 30, 2021 and December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2021 and December 31, 2020.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the balance sheet.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Derivative warrant liabilities	Derivative Warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to FASB ASC Topic 480 and ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued in connection with the Initial Public Offering and Private Placement were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Warrants issued in connection with our Initial Public Offering have subsequently been measured based on the listed market price of such warrants.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred in connection with the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities were expensed as incurred and presented as non-operating non-current
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2021, 48,300,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. There were no Class A ordinary shares issued or outstanding as of December 31, 2020.​​​​​​​ Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.​​​​​​​
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes” (“ASC 740”), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC more-likely-than-not There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net income ( loss) per ordinary shares	Net income ( loss) per ordinary share The Company has two classes of shares issued and outstanding: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 17,876,330, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the three and nine months ended September 30, 2021. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share, as the redemption value approximates fair value. The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each ordinary share class: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 4,640,279 $ 1,160,070 $ 4,279,869 $ 1,050,030 Denominator: Basic and diluted weighted average common shares outstanding 48,300,000 12,075,000 48,300,000 11,850,000 Basic and diluted net income per common share $ 0.10 $ 0.10 $ 0.09 $ 0.09
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) 815-40): 2020-06”), 2020-06 The Company’s management does not believe that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	9 Months Ended
	Sep. 30, 2021
Prior Period Adjustment [Abstract]
Summary of restatement on the balance sheets, statements of operations and statements of cash flows	As of February 9, 2021 As Previously Adjustment As Restated Total assets $ 486,762,576 $ 486,762,576 Total liabilities $ 42,383,637 $ 42,383,637 Class A ordinary shares subject to redemption 439,378,930 43,621,070 483,000,000 Preference shares — — — Class A ordinary shares 436 (436 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 5,780,890 (5,780,890 ) — Accumulated deficit (782,525 ) (37,839,744 ) (38,622,269 ) Total shareholders’ equity (deficit) $ 5,000,009 $ (43,621,070 ) $ (38,621,061 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 486,762,576 $ — $ 486,762,576 The impact of the restatement on the balance sheets, statements of operations and statements of cash flows for the Affected Quarterly Periods is presented below. The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of March 31, 2021: As of March 31, 2021 As Previously Adjustment As Restated Total assets $ 485,217,955 $ 485,217,955 Total liabilities $ 42,293,251 $ 42,293,251 Class A ordinary shares subject to redemption 437,924,700 45,075,300 483,000,000 Preference shares — — — Class A ordinary shares 451 (451 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 7,212,061 (7,212,061 ) — Accumulated deficit (2,213,716 ) (37,862,788 ) (40,076,504 ) Total shareholders’ equity (deficit) $ 5,000,004 $ (45,075,300 ) $ (40,075,296 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 485,217,955 $ — $ 485,217,955 The table below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the three months ended March 31, 2021: For the three months ended March 31, 2021 As Previously Adjustment As Restated Cash Flow used in Operating Activities $ (1,365,329 ) $ — $ (1,365,329 ) Cash Flow used in Investing Activities $ (483,000,000 ) $ — $ (483,000,000 ) Cash Flows provided by Financing Activities $ 485,508,800 $ — $ 485,508,800 Supplemental Disclosure of Noncash Financing Activities Offering costs included in accounts payable $ 84,340 $ — $ 84,340 Offering costs included in accrued expenses $ 85,450 $ — $ 85,450 Offering costs paid by related party under promissory note $ 104,788 $ — $ 104,788 Reversal of accrued expenses $ 25,000 $ — $ 25,000 Deferred legal fees $ 250,000 $ — $ 250,000 Deferred underwriting commissions $ 16,905,000 $ — $ 16,905,000 Initial value of Class A ordinary shares subject to possible redemption $ 439,378,930 $ (439,378,930 ) $ — Change in value of Class A ordinary shares subject to possible redemption $ (1,454,230 ) $ 1,454,230 $ — The tables below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported balance sheet as of June 30, 2021: As of June 30, 2021 As Previously Adjustment As Restated Total assets $ 484,399,219 $ 484,399,219 Total liabilities $ 39,746,028 $ 39,746,028 Class A ordinary shares subject to redemption 439,653,190 43,346,810 483,000,000 Preference shares — — — Class A ordinary shares 433 (433 ) — Class B ordinary shares 1,208 — 1,208 Additional paid-in 5,483,589 (5,483,589 ) — Accumulated deficit (485,229 ) (37,862,788 ) (38,348,017 ) Total shareholders’ equity $ 5,000,001 $ (43,346,810 ) $ (38,346,809 ) Total liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit $ 484,399,219 $ — $ 484,399,219 The table below present the effect of the financial statement adjustments related to the restatement discussed above of the Company’s previously reported statement of cash flows for the six months ended June 30, 2021: For the six months ended June 30, 2021 As Previously Adjustment As Restated Cash Flow used in Operating Activities $ (1,952,139 ) $ — $ (1,952,139 ) Cash Flows used in Investing Activities $ (483,000,000 ) $ — $ (483,000,000 ) Cash Flows provided by Financing Activities $ 485,409,010 $ — $ (485,409,010 ) Supplemental Disclosure of Noncash Financing Activities Offering costs included in accrued expenses $ 70,000 $ — $ (70,000 ) Offering costs paid by related party under promissory note $ 104,788 $ — $ (104,788 ) Reversal of accrued expenses $ 25,000 $ — $ (25,000 ) Deferred legal fees $ 250,000 $ — $ (250,000 ) Deferred underwriting commissions $ 16,905,000 $ — $ (16,905,000 ) Initial value of Class A ordinary shares subject to possible redemption $ 439,378,930 $ (439,378,930 ) $ — Change in value of Class A ordinary shares subject to possible redemption $ 274,260 $ (274,260 ) $ — In connection with the change in presentation for the Class A ordinary shares subject to possible redemption, the Company has revised its earnings per share calculation to allocate income and losses shared pro rata between the two classes of shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of shares participate pro rata in the income and losses of the Company. The impact to the reported amounts of weighted average shares outstanding and basic and diluted earnings per common share is presented below for the Affected Quarterly Periods: EPS for Class A ordinary shares (redeemable) As Previously Adjustment As Adjusted Form 10-Q (March 31, 2021) - three months ended March 31, 2021 Net loss $ (2,198,937 ) $ — $ (2,198,937 ) Weighted average shares outstanding 43,935,042 (17,160,042 ) 26,775,000 Basic and diluted earnings per share $ — ($0.06 ) ($0.06 ) Form 10-Q (June 30, 2021) - three months ended June 30, 2021 Net income $ 1,728,487 $— $ 1,728,487 Weighted average shares outstanding 43,794,369 (4,505,631 ) 48,300,000 Basic and diluted earnings per share $ — $ 0.03 $ 0.03 Form 10-Q (June 30, 2021) - six months ended June 30, 2021 Net loss $ (470,450 ) $ — $ (470,450 ) Weighted average shares outstanding 43,844,893 (6,366,204 ) 37,478,689 Basic and diluted earnings per share $ — ($0.01 ) ($0.01 ) EPS for Class B ordinary shares (non-redeemable) As Previously Adjustment As Adjusted Form 10-Q (March 31, 2021) - three months ended March 31, 2021 Net loss $ (2,198,937 ) $— $ (2,198,937 ) Weighted average shares outstanding 13,865,976 (2,492,878 ) 11,373,098 Basic and diluted earnings per share ($0.16 ) $ 0.10 ($0.06 ) Form 10-Q (June 30, 2021) - three months ended June 30, 2021 Net income $ 1,728,487 $ — $ 1,728,487 Weighted average shares outstanding 16,580,631 (4,505,631 ) 12,075,000 Basic and diluted earnings per share $ 0.10 ($0.07 ) $ 0.03 Form 10-Q (June 30, 2021) - six months ended June 30, 2021 Net loss $ (470,450 ) $— $ (470,450 ) Weighted average shares outstanding 15,230,803 (3,508,672 ) 11,722,131 Basic and diluted earnings per share ($0.03 ) $ 0.02 ($0.01 )

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2021
Earnings Per Share [Abstract]
Summary of Class A Ordinary Shares Subject to Possible Redemtion is Excluded from Earning Per Share	The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per share for each ordinary share class: For the Three Months Ended For the Nine Months Ended Class A Class B Class A Class B Basic and diluted net income per common share: Numerator: Allocation of net income $ 4,640,279 $ 1,160,070 $ 4,279,869 $ 1,050,030 Denominator: Basic and diluted weighted average common shares outstanding 48,300,000 12,075,000 48,300,000 11,850,000 Basic and diluted net income per common share $ 0.10 $ 0.10 $ 0.09 $ 0.09

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	9 Months Ended
	Sep. 30, 2021
Temporary Equity Disclosure [Abstract]
Summary Of Ordinary shares Issued Rrecognized in Class A Ordinary Shares Subject To Possible Redemption	The Class A ordinary shares issued in the Initial Public Offering were recognized in Class A ordinary shares subject to possible redemption as follows: Gross Proceeds $ 483,000,000 Proceeds from over-allotment 10,941,230 Less: Offering costs allocated to Class A shares subject to possible redemption (26,406,165 ) Proceeds allocated to Public Warrants at issuance (23,804,910 ) Plus: Accrection on Class A ordinary shares subject to possible redemption amount 39,269,845 Class A ordinary shares subject to possible redemption $ 483,000,000

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Schedule of company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Quoted Prices Significant Other Significant Other in Observable Unobservable Active Markets Inputs Inputs Description (Level 1) (Level 2) (Level 3) Assets: Investments held in Trust Account $ 483,040,207 $ — $ — Liabilities: Derivative warrant liabilities—public $ 8,790,600 $ — $ — Derivative warrant liabilities—private $ — $ — $ 7,476,860
Schedule of quantitative information regarding Level 3 fair value measurements inputs	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: February 9, 2021 As of September 30, 2021 Share price $ 9.73 $ 9.73 Volatility 24.2 % 18.2 % Expected life of the options to convert 6.18 5.71 Risk-free rate 0.65 % 1.10 % Dividend yield — —
Schedule of change in the fair value of the warrant liabilities	The change in the level 3 fair value of the derivative warrant liabilities for the nine months ended September 30, 2021 is summarized as follows: Derivative warrant liabilities at January 13, 2021 (inception) $ — Issuance of Public and Private Warrants 23,804,910 Change in fair value of derivative warrant liabilities 1,221,950 Transfer of Public Warrants to Level 1 (13,524,000 ) Derivative warrant liabilities at March 31, 2021 11,502,860 Change in fair value of derivative warrant liabilities (1,232,450 ) Derivative warrant liabilities at June 30, 2021 10,270,410 Change in fair value of derivative warrant liabilities (2,793,550 ) Derivative warrant liabilities at September 30, 2021 $ 7,476,860

Description of Organization a_2

Description of Organization and Business Operations (Details)	Feb. 09, 2021USD ($)$ / sharesshares	Oct. 14, 2020	Sep. 30, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination number of businesses minimum		1
Deferred underwriting commission			$ 250,000
Proceeds from issuance initial public offering			483,000,000
Proceeds received from private placement			$ 12,324,495
Threshold minimum aggregate fair market value as a percentage of the net assets held in the Trust Account			80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination			50.00%
Minimum net tangible assets upon consummation of the Business Combination			$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent			15.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)			100.00%
Redemption period upon closure			10 days
Business combination closing months			24 months
Maximum net interest to pay dissolution expenses			$ 100,000
Cash operating bank account			191,011
Working capital			836
Aggregate purchase price			25,000
Loan from the Sponsor			30,212
Loans from working capital			0
Sponsor
Subsidiary, Sale of Stock [Line Items]
Loan from the Sponsor			$ 135,000
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares			8,216,330
Price of warrant | $ / shares			$ 1.50
Proceeds received from private placement			$ 12,300,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Underwriting commission	$ 16,900,000
Deferred underwriting commission	$ 250,000
Sale of units in initial public offering, less allocation of proceeds to Public Warrants (in shares) | shares	48,300,000
Purchase price, per unit | $ / shares	$ 10
Proceeds from issuance initial public offering	$ 483,000,000
Offering Costs	$ 27,100,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less allocation of proceeds to Public Warrants (in shares) | shares	483,000,000
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares	8,216,330
Price of warrant | $ / shares	$ 1.50
Proceeds received from private placement	$ 12,300,000
Over-Allotment Units
Subsidiary, Sale of Stock [Line Items]
Sale of units in initial public offering, less allocation of proceeds to Public Warrants (in shares) | shares	6,300,000
Purchase price, per unit | $ / shares	$ 10

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Additional Information (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 09, 2021	Dec. 31, 2020
Additional Paid in Capital					$ 23,792
Retained Earnings (Accumulated Deficit)	$ (32,547,668)	$ (38,348,017)	$ (40,076,504)	$ (38,622,269)	$ (14,779)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid in Capital		5,700,000
Retained Earnings (Accumulated Deficit)		37,800,000
Reclassification of permanent to temporary equity		$ 43,600,000

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Summary of Restatement On The Balance Sheets (Details) - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Feb. 09, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Assets	$ 483,987,885	$ 484,399,219	$ 485,217,955	$ 486,762,576	$ 35,221
Total Liabilities	33,534,345	39,746,028	42,293,251	42,383,637	25,000
Class A ordinary shares subject to redemption	483,000,000			483,000,000
Preferred stock	0		0		0
Additional paid-in capital					23,792
Accumulated deficit	(32,547,668)	(38,348,017)	(40,076,504)	(38,622,269)	(14,779)
Total shareholders' (deficit) equity	(32,546,460)	(38,346,809)	(40,075,296)	(38,621,061)	10,221
Total Liabilities and Shareholders' (Deficit) Equity	483,987,885	484,399,219	485,217,955	486,762,576	35,221
Class A Common Stock Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption		483,000,000	483,000,000
Class A Common Stock Not Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock			0
Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock	0				0
Total shareholders' (deficit) equity	0	0	0		0
Class B Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock	1,208	1,208	1,208	1,208	1,208
Total shareholders' (deficit) equity	$ 1,208	1,208	1,208		$ 1,208
Previously Reported [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Total Assets		484,399,219	485,217,955	486,762,576
Total Liabilities		39,746,028	42,293,251	42,383,637
Class A ordinary shares subject to redemption				439,378,930
Preferred stock		0	0
Additional paid-in capital		5,483,589	7,212,061	5,780,890
Accumulated deficit		(485,229)	(2,213,716)	(782,525)
Total shareholders' (deficit) equity		5,000,001	5,000,004	5,000,009
Total Liabilities and Shareholders' (Deficit) Equity		484,399,219	485,217,955	486,762,576
Previously Reported [Member] | Class A Common Stock Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption		439,653,190	437,924,700
Previously Reported [Member] | Class A Common Stock Not Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock		433	451
Previously Reported [Member] | Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock				436
Previously Reported [Member] | Class B Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock		1,208	1,208	1,208
Adjustment [Member]
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Class A ordinary shares subject to redemption		43,346,810	45,075,300	43,621,070
Preferred stock		0	0
Additional paid-in capital		(5,483,589)	(7,212,061)	(5,780,890)
Accumulated deficit		(37,862,788)	(37,862,788)	(37,839,744)
Total shareholders' (deficit) equity		(43,346,810)	(45,075,300)	(43,621,070)
Adjustment [Member] | Class A Common Stock Not Subject to Redemption
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock		$ (433)	$ (451)
Adjustment [Member] | Class A Common Stock
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Common stock				$ (436)

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Summary of Restatement On The Cash Flow (Details) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Cash Flow used in Operating Activities	$ (1,365,329)	$ (1,952,139)	$ (2,217,999)
Cash Flow used in Investing Activities	(483,000,000)	(483,000,000)	(483,000,000)
Cash Flows provided by Financing Activities	485,508,800	(485,409,010)	485,409,010
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Offering costs included in accounts payable	84,340
Offering costs included in accrued expenses	85,450	(70,000)	70,000
Offering costs paid by related party under promissory note	104,788	(104,788)	104,788
Reversal of accrued expenses	25,000	(25,000)	25,000
Deferred legal fees	250,000	(250,000)	250,000
Deferred underwriting commissions	16,905,000	(16,905,000)	$ 16,905,000
Previously Reported [Member]
Cash Flow used in Operating Activities	(1,365,329)	(1,952,139)
Cash Flow used in Investing Activities	(483,000,000)	(483,000,000)
Cash Flows provided by Financing Activities	485,508,800	485,409,010
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Offering costs included in accounts payable	84,340
Offering costs included in accrued expenses	85,450	70,000
Offering costs paid by related party under promissory note	104,788	104,788
Reversal of accrued expenses	25,000	25,000
Deferred legal fees	250,000	250,000
Deferred underwriting commissions	16,905,000	16,905,000
Initial value of Class A ordinary shares subject to possible redemption	439,378,930	439,378,930
Change in value of Class A ordinary shares subject to possible redemption	(1,454,230)	274,260
Adjustment [Member]
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Initial value of Class A ordinary shares subject to possible redemption	(439,378,930)	(439,378,930)
Change in value of Class A ordinary shares subject to possible redemption	$ 1,454,230	$ (274,260)

Restatement of Previously Iss_6

Restatement of Previously Issued Financial Statements - Summary of Restatement On The Operation (Details) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Net income (loss)	$ 5,800,349	$ 1,728,487	$ (2,198,937)		$ 5,329,899
Weighted average shares outstanding	12,075,000				11,850,000
Basic and diluted earnings per share	$ 0.10				$ 0.10
Class A Redeemable Ordinary Shares [Member]
Net income (loss)		$ 1,728,487,000	$ (2,198,937,000)	$ (470,450,000)
Weighted average shares outstanding		48,300,000	26,775,000	37,478,689
Basic and diluted earnings per share		$ 0.03	$ 0.06	$ 0.01
Class A Redeemable Ordinary Shares [Member] | Previously Reported [Member]
Net income (loss)		$ 1,728,487,000	$ (2,198,937,000)	$ (470,450,000)
Weighted average shares outstanding		43,794,369	43,935,042	43,844,893
Class A Redeemable Ordinary Shares [Member] | Adjustment [Member]
Weighted average shares outstanding		(4,505,631)	(17,160,042)	(6,366,204)
Basic and diluted earnings per share		$ 0.03	$ 0.06	$ 0.01
Class B Non Redeemable Ordinary Shares Member [Member]
Net income (loss)		$ 1,728,487,000	$ (2,198,937,000)	$ (470,450,000)
Weighted average shares outstanding		12,075,000	11,373,098	11,722,131
Basic and diluted earnings per share		$ 0.03	$ 0.06	$ 0.01
Class B Non Redeemable Ordinary Shares Member [Member] | Previously Reported [Member]
Net income (loss)		$ 1,728,487,000	$ (2,198,937,000)	$ (470,450,000)
Weighted average shares outstanding		16,580,631	13,865,976	15,230,803
Basic and diluted earnings per share		$ 0.10	$ 0.16	$ 0.03
Class B Non Redeemable Ordinary Shares Member [Member] | Adjustment [Member]
Weighted average shares outstanding		(4,505,631)	(2,492,878)	(3,508,672)
Basic and diluted earnings per share		$ 0.07	$ 0.10	$ 0.02

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Nov. 01, 2021	Feb. 09, 2021	Dec. 31, 2020
Cash equivalents	$ 0			$ 0
Derivative warrant liabilities	16,267,500		$ 23,800,000
FDIC Insurance coverage amount	250,000
Class A ordinary shares subject to possible redemption				0
Unrecognized tax benefits	0
Unrecognized tax benefits accrued for interest and penalties	$ 0
Anti-dilutive securities attributable to warrants (in shares)	17,876,330
Minimum networth needed to consummate a business combination	$ 5,000,001
Class A ordinary shares issued				0
Class A Common Stock
Class A ordinary shares subject to possible redemption	48,300,000			0
Class A ordinary shares issued				0
Class A ordinary Shares Subject to Possible Redemption
Class A ordinary shares subject to possible redemption		48,300,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Class A Ordinary Shares Subject to Possible Redemtion is Excluded from Earning Per Share (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2021
Numerator:
Allocation of net income	$ 5,800,349	$ 1,728,487	$ (2,198,937)	$ 5,329,899
Denominator:
Basic and diluted weighted average common shares outstanding	12,075,000			11,850,000
Basic and diluted net income per common share	$ 0.10			$ 0.10
Class A Common Stock
Numerator:
Allocation of net income	$ 4,640,279			$ 4,279,869
Denominator:
Basic and diluted weighted average common shares outstanding	48,300,000			48,300,000
Basic and diluted net income per common share	$ 0.10			$ 0.09
Class B Common Stock
Numerator:
Allocation of net income	$ 1,160,070			$ 1,050,030
Denominator:
Basic and diluted weighted average common shares outstanding	12,075,000			11,850,000
Basic and diluted net income per common share	$ 0.10			$ 0.09

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Feb. 09, 2021	Mar. 31, 2021	Jun. 30, 2021	Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds received from initial public offering, gross				$ 483,000,000
Offering costs				9,810,697
Deferred underwriting commissions				16,905,000
Deferred legal fees		$ 250,000	$ (250,000)	$ 250,000
Public Warrant
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrants				$ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	48,300,000
Purchase price, per unit	$ 10
Proceeds received from initial public offering, gross	$ 483,000,000
Offering costs	27,100,000
Deferred underwriting commissions	16,900,000			$ 16,900,000
Deferred legal fees	$ 250,000
Initial Public Offering | Public Warrant
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit	1
Number of warrants in a unit	0.2
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Over-Allotment Units
Subsidiary, Sale of Stock [Line Items]
Number of units issued	6,300,000
Purchase price, per unit	$ 10

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details)	Jan. 30, 2021shares	Dec. 31, 2020USD ($)shares	Sep. 30, 2021USD ($)Day$ / sharesshares	Feb. 09, 2021shares
Related Party Transaction [Line Items]
Aggregate purchase price | $			$ 25,000
Class B Common Stock
Related Party Transaction [Line Items]
Stock split ratio	1.2
Common shares, shares outstanding (in shares)	12,075,000	12,075,000	12,075,000	10,062,500
Shares subject to forfeiture	1,575,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders			20.00%
Founder Shares | Sponsor | Class B Common Stock
Related Party Transaction [Line Items]
Aggregate purchase price | $		$ 25,000
Number of shares issued		10,062,500
Stock split ratio	1.2
Common shares, shares outstanding (in shares)	12,075,000
Shares subject to forfeiture	1,575,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders	20.00%
Shares no longer subject to forfeiture				1,575,000
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares			$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | Day			20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination | Day			30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences			150 days

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Feb. 09, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Proceeds received from issuance of warrants		$ 12,324,495
Private Placement Warrants
Related Party Transaction [Line Items]
Number of warrants issued	8,216,330	8,216,330
Proceeds received from issuance of warrants		$ 12,300,000
Exercise price of warrants	$ 11.50	$ 11.50
Period after completion of initial business combination		30 days
Price of warrant	$ 1.50	$ 1.50
Administrative Services Agreement
Related Party Transaction [Line Items]
Expenses per month		$ 20,000
Period from the closing of The offering for calculating expenses		24 months
Expenses incurred and paid	$ 60,000	$ 160,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note				$ 300,000
Amount borrowed			$ 135,000
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Loan conversion agreement warrant	$ 1,500,000	$ 1,500,000
Price of warrant	$ 1.50	$ 1.50

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)	Feb. 09, 2021	Sep. 30, 2021
Commitments & contingencies [Line Items]
Granted Term	45 days
Underwriting cash discount per unit		$ 0.20
Underwriter cash discount		$ 9,700,000
Deferred commission per unit		$ 0.35
Deferred underwriting commissions		$ 16,905,000
Over-Allotment Units
Commitments & contingencies [Line Items]
Number of units issued	6,300,000
Initial Public Offering
Commitments & contingencies [Line Items]
Number of units issued	48,300,000
Deferred underwriting commissions	$ 16,900,000	$ 16,900,000

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption - Summary Of Ordinary shares Issued Rrecognized in Class A Ordinary Shares Subject To Possible Redemption (Details) - USD ($)	Sep. 30, 2021	Feb. 09, 2021
Temporary Equity Disclosure [Abstract]
Gross Proceeds	$ 483,000,000
Proceeds from over-allotment	10,941,230
Offering costs allocated to Class A shares subject to possible redemption	(26,406,165)
Proceeds allocated to Public Warrants at issuance	(23,804,910)
Accrection on Class A ordinary shares subject to possible redemption amount	39,269,845
Class A ordinary shares subject to possible redemption	$ 483,000,000	$ 483,000,000

Class A Ordinary Shares Subje_4

Class A Ordinary Shares Subject to Possible Redemption - Additional Information (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Temporary Equity [Line Items]
Temporary equity shares outstanding		0
Temporary Equity, Shares Issued		0
Class A Common Stock
Temporary Equity [Line Items]
Temporary equity shares authorized	500,000,000
Temporary equity par or stated value per share	$ 0.0001
Temporary equity shares outstanding	48,300,000	0
Temporary Equity, Shares Issued		0

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock Shares (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
Preferred shares, shares authorized	5,000,000	5,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Shares (Details)	Jan. 30, 2021shares	Sep. 30, 2021VOTE$ / sharesshares	Feb. 09, 2021shares	Dec. 31, 2020$ / sharesshares
Class A Common Stock Not Subject to Redemption
Class of Stock [Line Items]
Common shares, shares authorized (in shares)		500,000,000		500,000,000
Common shares, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Common shares, votes per share | VOTE		1
Common shares, shares issued (in shares)		48,300,000
Common shares, shares outstanding (in shares)		48,300,000
Class A Common Stock
Class of Stock [Line Items]
Common shares, shares issued (in shares)				0
Common shares, shares outstanding (in shares)				0
Class B Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)		50,000,000		50,000,000
Common shares, par value (in dollars per share) | $ / shares		$ 0.0001		$ 0.0001
Common shares, shares issued (in shares)		12,075,000	10,062,500	12,075,000
Common shares, shares outstanding (in shares)	12,075,000	12,075,000	10,062,500	12,075,000
Stock split ratio	1.2
Shares subject to forfeiture	1,575,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20.00%
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	20.00%

Derivative Warrant Liabilities

Derivative Warrant Liabilities (Details)	9 Months Ended
	Sep. 30, 2021item$ / sharesshares	Dec. 31, 2020shares
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrant outstanding | shares	8,216,330	0
Exercise price of warrants	$ 11.50
Restrictions on transfer period of time after business combination completion	30 days
Public Warrant
Class of Warrant or Right [Line Items]
Warrant outstanding | shares	9,660,000	0
Warrant exercise period condition one	30 days
Warrant exercise period condition two	12 months
Public Warrants expiration term	5 years
Threshold period for filling registration statement after business combination | item	20
Maximum threshold period for registration statement to become effective after business combination | item	60
Exercise price of warrants	$ 11.50
Share price	$ 9.20
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	10
Percentage of gross new proceeds to total equity proceeds used to measure dilution of warrant	60
Public Warrant | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Class of warrants exercise price adjustment percentage	115.00%
Warrant redemption condition minimum share price	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	30
Redemption period	30 days
Share price trigger used to measure dilution of warrant	$ 18
Public Warrant | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Class of warrants exercise price adjustment percentage	180.00%
Warrant redemption condition minimum share price	$ 10
Warrant redemption condition minimum share price scenario two	18
Redemption price per public warrant (in dollars per share)	$ 0.10
Threshold trading days for redemption of public warrants | item	20
Threshold consecutive trading days for redemption of public warrants | item	30
Redemption period	30 days
Share price trigger used to measure dilution of warrant	$ 10

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	9 Months Ended
	Sep. 30, 2021	Feb. 09, 2021
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	$ 16,267,500	$ 23,800,000
Fair value assets level 1 to level 2 transfers	0
Fair value assets level 2 to level 1 transfers	0
Fair value assets transferred into (out of) level 3	3
Level 1
Assets:
Investments held in Trust Account	483,040,207
Level 1 | Private Placement Warrants
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	7,476,860
Level 1 | Public Warrant
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	$ 8,790,600

Fair Value Measurements - Level

Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021USD ($)yr	Sep. 30, 2021USD ($)yr	Feb. 09, 2021yr
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Decrease in fair value of liabilities | $	$ 6.1	$ 7.5
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	9.73	9.73	9.73
Volatility | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.182	0.182	0.242
Expected life of the options to convert | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input | yr	5.71	5.71	6.18
Risk-free rate | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.0110	0.0110	0.0065

Fair Value Measurements - Chang

Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Mar. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Transfer of Public Warrants to Level 1	$ (6,077,950)		$ (7,537,410)
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Issuance of Public and Private Warrants			23,804,910
Change in fair value of derivative warrant liabilities	(2,793,550)	$ (1,232,450)	1,221,950
Transfer of Public Warrants to Level 1			(13,524,000)
Derivative warrant liabilities at September 30, 2021	$ 7,476,860	$ 10,270,410	$ 7,476,860	$ 11,502,860